Suchergebnisse - "Milla, Carlos"

PubPharm (29)

1

Treatment of Fetal Cystic Fibrosis With Cystic Fibrosis Transmembrane Conductance Regulator Modulation Therapy

enthalten in: Annals of internal medicine | 2023

von Blumenfeld, Y. | Hintz, S. | Aziz, N. | +4

2

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis : A Clinical Trial

enthalten in: American journal of respiratory and critical care medicine | 2022

von Nichols, D. | Paynter, A. | Heltshe, S. | +121

CommentIn: Am J Respir Crit Care Med. 2022 Mar 1;205(5):487-489. - PMID 35073504

3

Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND) : an open-label extension study

enthalten in: The Lancet. Respiratory medicine | 2021

von Flume, P. | Biner, R. | Downey, D. | +118

ErratumIn: Lancet Respir Med. 2021 Apr;9(4):e38. - PMID 33636124

4

Long-term safety and efficacy of lumacaftor-ivacaftor therapy in children aged 6-11 years with cystic fibrosis homozygous for the F508del-CFTR mutation : a phase 3, open-label, extension study

enthalten in: The Lancet. Respiratory medicine | 2021

von Chilvers, M. | Davies, J. | Milla, C. | +5

ErratumIn: Lancet Respir Med. 2021 Apr;9(4):e38. - PMID 33607008

5

High-Efficiency, Selection-free Gene Repair in Airway Stem Cells from Cystic Fibrosis Patients Rescues CFTR Function in Differentiated Epithelia

enthalten in: Cell stem cell | 2020

von Vaidyanathan, S. | Salahudeen, A. | Sellers, Z. | +21

CommentIn: Cell Stem Cell. 2020 Apr 2;26(4):476-478. - PMID 32243806

6

Proof of concept for identifying cystic fibrosis from perspiration samples

enthalten in: Proceedings of the National Academy of Sciences of the United States of America | 2019

von Zhou, Z. | Alvarez, D. | Milla, C. | +1

7

Salivary Thiocyanate as a Biomarker of Cystic Fibrosis Transmembrane Regulator Function

enthalten in: Analytical chemistry | 2019

von Malkovskiy, A. | Yacob, A. | Dunn, C. | +5

8

Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults

enthalten in: Scientific reports | 2018

von Kim, J. | Farahmand, M. | Dunn, C. | +5

9

Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL) : a phase 3 single-arm study

enthalten in: The Lancet. Respiratory medicine | 2018

von Rosenfeld, M. | Wainwright, C. | Higgins, M. | +38

CommentIn: Lancet Respir Med. 2018 Jul;6(7):483-484. - PMID 29886025

10

Ivacaftor restores CFTR-dependent sweat gland fluid secretion in cystic fibrosis subjects with S945L alleles

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2018

von Kim, J. | Davies, Z. | Dunn, C. | +2